Finch Therapeutics Group, Inc.
FNCH
$12.75
$0.201.59%
OTC PK
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 16.04M | 20.76M | 25.12M | 28.78M | 34.05M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.24M | 413.00K | 723.00K | 1.14M | 2.45M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 17.28M | 21.18M | 25.85M | 29.92M | 36.50M |
|
|||||
Total Current Assets | 17.28M | 21.18M | 25.85M | 29.92M | 36.50M |
Net Property, Plant & Equipment | 25.95M | 26.57M | 27.18M | 27.23M | 28.04M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.35M | 2.35M | 2.35M | 2.35M | 2.32M |
Total Assets | 45.58M | 50.09M | 55.37M | 59.49M | 66.86M |
|
|||||
Total Accounts Payable | 29.00K | 47.00K | 141.00K | 357.00K | 432.00K |
Total Accrued Expenses | 2.34M | 1.38M | 1.54M | 2.55M | 7.49M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.09M | 2.01M | 1.72M | 1.97M | 1.66M |
Total Finance Division Other Current Liabilities | -- | 66.00K | 678.00K | -- | -- |
Total Other Current Liabilities | -- | 66.00K | 678.00K | -- | -- |
Total Current Liabilities | 4.46M | 3.50M | 4.08M | 4.88M | 9.58M |
|
|||||
Total Current Liabilities | 4.46M | 3.50M | 4.08M | 4.88M | 9.58M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 26.90M | 27.56M | 28.40M | 28.80M | 29.39M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 31.36M | 31.05M | 32.49M | 33.68M | 38.96M |
|
|||||
Common Stock & APIC | 373.32M | 373.31M | 373.28M | 373.17M | 372.83M |
Retained Earnings | -359.11M | -354.27M | -350.40M | -347.35M | -344.94M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 14.22M | 19.04M | 22.89M | 25.81M | 27.89M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 14.22M | 19.04M | 22.89M | 25.81M | 27.89M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 14.22M | 19.04M | 22.89M | 25.81M | 27.89M |
|